(19) |
 |
|
(11) |
EP 0 318 935 A3 |
(12) |
EUROPEAN PATENT APPLICATION |
(88) |
Date of publication A3: |
|
29.08.1990 Bulletin 1990/35 |
(43) |
Date of publication A2: |
|
07.06.1989 Bulletin 1989/23 |
(22) |
Date of filing: 29.11.1988 |
|
|
(84) |
Designated Contracting States: |
|
AT BE CH DE ES FR GB GR IT LI LU NL SE |
(30) |
Priority: |
30.11.1987 US 126372 14.10.1988 US 256221
|
(71) |
Applicant: WARNER-LAMBERT COMPANY |
|
Morris Plains
New Jersey 07950 (US) |
|
(72) |
Inventors: |
|
- Bigge, Christopher Franklin
Ann Arbor
Michigan 48103 (US)
- Drummond, James Thomas
Ypsilanti
Michigan 48197 (US)
- Gregor, Vlad Edward
Ann Arbor
Michigan 48105 (US)
- Johnson, Graham
Ann Arbor
Michigan 48103 (US)
- Pavia, Michael Raymond
Ann Arbor
Michigan 48104 (US)
|
(74) |
Representative: Mansmann, Ivo |
|
Gödecke AG
Patentwesen
Mooswaldallee 1-9 79090 Freiburg 79090 Freiburg (DE) |
|
|
|
|
|
Remarks: |
|
Claims for the following Contracting States: ES + GR. |
|
(54) |
Substituted alpha-amino acids having pharmaceutical activity |
(57) The present invention is novel substituted a-amino acids, pharmaceutical compositions,
methods of use, and preparations therefore having utility for treating disorders which
benefit from blockade of aspartate and glutamate receptors.